Global Peripheral IV Catheter PIVC Market Size By Type (Short PIVC, Integrated/Closed PIVC), By Application (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Peripheral IV Catheter (PIVC) Market was valued at USD 4.9 billion in 2023 and is projected to reach USD 8.4 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. This growth is primarily fueled by the increasing prevalence of chronic diseases, rising hospitalization rates, and the growing demand for minimally invasive procedures. PIVCs are widely used in hospitals and outpatient settings for the administration of medications, fluids, and nutrients, making them a critical component of patient care.

Drivers:

1. Rising Hospitalization and Surgical Procedures:

An increase in the number of surgeries and hospital admissions globally is leading to a greater need for reliable intravenous access, propelling the demand for PIVCs.

2. Increasing Incidence of Chronic Diseases:

Chronic conditions such as diabetes, cancer, and cardiovascular diseases often require long-term IV therapy, thereby increasing the utilization of peripheral IV catheters.

3. Advancements in PIVC Design:

Manufacturers are introducing catheters with advanced features like safety-engineered designs, antimicrobial coatings, and improved materials to reduce complications such as phlebitis and catheter-related bloodstream infections.

Restraints:

1. Risk of Complications:

Peripheral IV catheter use is associated with complications such as infiltration, phlebitis, and infection, which can impact patient outcomes and limit market adoption.

2. Skilled Personnel Requirement:

Proper insertion and management of PIVCs require trained healthcare providers. In regions with a shortage of skilled professionals, the improper use can result in increased complication rates.

Opportunity:

1. Expansion in Home Healthcare Settings:

With the growing shift toward home-based care and ambulatory services, PIVCs designed for ease of use and safety are increasingly in demand.

2. Technological Innovation and Smart Catheters:

The integration of sensor technology and real-time monitoring capabilities is an emerging trend, offering vast potential for improved safety and efficiency in IV therapy.

Market by System Type Insights:

Based on system type, the Integrated/Closed IV Catheters segment dominated the market in 2023. These catheters minimize blood exposure and reduce the risk of contamination and needlestick injuries. The segment is expected to grow further due to increased focus on infection control and patient safety.

Market by End-use Insights:

The Hospitals segment was the largest revenue contributor in 2023, accounting for over 55% of the market share. The high volume of inpatient care, emergency procedures, and infusion therapies performed in hospital settings makes them the primary users of PIVCs. Ambulatory surgical centers and home care are emerging segments with strong growth potential due to the rise in outpatient care.

Market by Regional Insights:

North America led the market in 2023, owing to its well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong focus on patient safety. Asia-Pacific is expected to register the fastest growth during the forecast period, driven by rising healthcare expenditures, growing awareness, and increasing investments in hospital infrastructure in countries such as China and India.

Competitive Scenario:

Key players in the Global PIVC Market include Becton, Dickinson and Company (BD), Smiths Medical, B. Braun Melsungen AG, Terumo Corporation, Nipro Medical Corporation, ICU Medical Inc., Vygon, and Argon Medical Devices. These companies are actively pursuing product innovation, regulatory approvals, and geographic expansion. Notable developments include:

2023: BD launched an advanced antimicrobial-coated catheter designed to reduce infection rates in high-risk patients.

2024: ICU Medical Inc. expanded its product line with smart catheters equipped with real-time monitoring for fluid administration.

2025: B. Braun announced a partnership with AI startups to develop predictive analytics tools for early detection of catheter complications.

Scope of Work – Global Peripheral IV Catheter (PIVC) Market

Report Metric Details

Market Size (2023) USD 4.9 Billion

Projected Market Size (2031) USD 8.4 Billion

CAGR (2023–2031) 6.9%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising Hospitalization, Chronic Diseases, Technological Advancements

Opportunities Home Healthcare Adoption, Smart Catheter Innovation

Key Market Developments:

2023: BD unveiled a closed IV catheter system with enhanced safety features, reducing needlestick injuries by 60%.

2024: Smiths Medical introduced a high-flow catheter for rapid infusion therapy in emergency care.

2025: Terumo Corporation received regulatory approval for a novel PIVC optimized for pediatric use.

FAQs:

1. What is the current market size of the Global Peripheral IV Catheter (PIVC) Market?

The market was valued at USD 4.9 billion in 2023.

2. What is the major growth driver of the Global Peripheral IV Catheter (PIVC) Market?

The major growth drivers include rising hospitalization rates, chronic disease prevalence, and advances in catheter design.

3. Which is the largest region during the forecast period in the Global Peripheral IV Catheter (PIVC) Market?

North America holds the largest market share due to advanced healthcare systems and high adoption of medical technologies.

4. Which segment accounted for the largest market share in the Global Peripheral IV Catheter (PIVC) Market?

The Integrated/Closed IV Catheters segment held the largest market share in 2023.

5. Who are the key market players in the Global Peripheral IV Catheter (PIVC) Market?

Key players include BD, Smiths Medical, B. Braun, Terumo Corporation, Nipro Medical, ICU Medical, Vygon, and Argon Medical Devices.